February 27, 2020

Novocure Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Company Update

Quarterly net revenues of $99.2 million, representing 42 percent growth versus the fourth quarter 2018 and 8 percent growth versus the third quarter 2019 Second quarter of positive net income with $0.04 in earnings per share Four phase 3 pivotal clinical trials ongoing creating the potential… Read More
learn more